Biotron Ltd Sustainability Reports
Biotron Limited is an Australian clinical-stage biotechnology company that develops and commercializes small molecule drugs targeting viral diseases with unmet medical needs. Its primary focus is on viroporin-targeting antiviral therapies for diseases such as HIV-1, Hepatitis B, and coronaviruses.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
FIGI: BBG001S5YKL0
18 reports from 2006 to 2025
Company Profile
Biotron Limited is an Australian clinical-stage biotechnology company that develops and commercializes small molecule drugs targeting viral diseases with unmet medical needs. Its primary focus is on viroporin-targeting antiviral therapies for diseases such as HIV-1, Hepatitis B, and coronaviruses.
Reports
18 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
